Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID VA26014F3894· VHA· 260-NETWORK CONTRACT OFFICE 20· 6505 · DRUGS AND BIOLOGICALS· FY2014· $258,169 net obligations· UEI DKCXLGANZAN3· CT

Description

SOLIRIS

First action · last action
2013-10-01 · 2015-02-03
Transactions
2
First transaction's obligation
$311,552
Base + all options value (sum of deltas)
$258,169
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30015
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$311,552$0Base award · 2013-10-01 · this action $311,552 · running total $311,552Modification P00001 · 2015-02-03 · this action -$53,383 · running total $258,169
  • Base2013-10-01+$311,552= $311,552
  • Mod P000012015-02-03-$53,383= $258,169
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-10-01+$311,552$311,552SOLIRIS
Mod P00001· FUNDING ONLY ACTION2015-02-03−$53,383$258,169SOLIRIS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26016F0697LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20$6,829FY2016
VA26016F0673UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20$8,906FY2016
VA26016J0622SANOFI VACCINES US INC.260-NETWORK CONTRACT OFFICE 20$396,690FY2016
VA26016J0621SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$176,120FY2016
VA26016J0613SEQIRUS USA INC260-NETWORK CONTRACT OFFICE 20$74,617FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26014F3894_3600_V797D30015_3600 · retrieved 2026-09-26.